Lisata Therapeutics, Inc. (LSTA) stock
LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.09−0.12 (-9.92%)
Close on Nov 16, 2026Market cap $9.82MP/E –Yield –
Lisata Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Lisata Therapeutics's price to sales ratio was 109.4× on Nov 11, 2026, against 16.9× a year earlier. Over the last 5 years it ranged from 0.8× to 260.3×, with a median of 7.6×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 109.4× | +94.2 |
| 2025 | Dec 31, 2025 | 15.2× | +14.0 |
| 2018 | Feb 28, 2018 | 1.3× | +0.3 |
| 2017 | Dec 29, 2017 | 0.9× | +0.0 |
| 2016 | Dec 30, 2016 | 0.9× | −3.1 |
| 2015 | Dec 31, 2015 | 4.0× | −7.0 |
| 2014 | Apr 30, 2014 | 11.0× | −41.4 |
| 2013 | Dec 31, 2013 | 52.3× | +44.8 |
| 2012 | Dec 31, 2012 | 7.5× | +6.3 |
| 2011 | Dec 30, 2011 | 1.2× | – |
See a number that looks wrong?